ArticleProteome science2009

Prediction of outcome of non-small cell lung cancer patients treated with chemotherapy and bortezomib by time-course MALDI-TOF-MS serum peptide profiling.

Johannes Voortman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.